Mercadolibre Inc vs Smith & Nephew plc — how do they compare? Mercadolibre Inc trades at $1,889.85 (market cap $94.13B), while Smith & Nephew plc trades at $27.24 (market cap $11.10B). The key difference: Mercadolibre Inc is far larger — about 8.5× Smith & Nephew plc's market cap, and Smith & Nephew plc pays a 2.95% dividend while Mercadolibre Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Mercadolibre Inc for 117 Days and Smith & Nephew plc for 121 Days on average.
| MELI | SNN | |
|---|---|---|
Market Cap | $94.13B | $11.10B |
Volume | 273,781 | 1,051,703 |
Sector | Consumer Cyclical | Health |
52-Week High | $2.36K | $37.17 |
52-Week Low | $1.55K | $26.42 |
Typical Hold Time | 117 Days | 121 Days |
Enterprise Value | $101.77B | $14.13B |
Dividend Yield | — | 2.95% |
Signals from Pluang's Aura AI — not financial advice
MercadoLibre (MELI) trades at $1,856.66, down 0.86% on the day, with the stock showing strong fundamental growth despite recent earnings volatility. The company maintains robust revenue expansion, reaching $28.89 billion in 2025, while technical indicators show a bullish trend with support at $1,842 and resistance at $1,870. Recent news highlights MercadoLibre's dominant position in Latin American e-commerce and fintech, with new service expansions in Brazil.
MELI presents a compelling growth story with strong analyst support (24 buy ratings, 0 sell) and a consensus price target of $2,170. However, investors face risks from profit margin compression and macroeconomic headwinds in key markets like Argentina, requiring careful monitoring of execution against high valuation multiples.
Smith+Nephew (SNN) trades at $26.96, near its 52-week low, with bearish technical signals despite recent earnings beats. The company shows strong fundamentals with revenue growth to $6.16B in 2025 and improving profit margins of 10.08%. Recent product launches in trauma care and surgical robotics highlight innovation, but analyst sentiment remains cautious with 65% hold ratings.
Investment outlook is mixed: solid fundamentals and product pipeline offer upside, but technical weakness and analyst skepticism pose near-term risks. Key catalysts include execution on new product adoption and margin expansion, while risks involve competitive pressures and leadership transitions following the CFO's departure.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
MercadoLibre runs the largest e-commerce marketplace in Latin America, connecting a network of more than 140 million active users and 1 million active sellers as of the end of 2021 across an 18-country footprint. The company also operates a host of complementary businesses, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.
Read more on MELI →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →